|
KIAA0196 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07750000000184E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0194999994505E-07 |
| Normal-vs-Stage2 |
8.811900E-02 |
| Normal-vs-Stage3 |
5.971800E-01 |
| Normal-vs-Stage4 |
2.076000E-01 |
| Stage1-vs-Stage2 |
1.551560E-01 |
| Stage1-vs-Stage3 |
1.936420E-02 |
| Stage1-vs-Stage4 |
5.648000E-01 |
| Stage2-vs-Stage3 |
5.211400E-01 |
| Stage2-vs-Stage4 |
6.574600E-01 |
| Stage3-vs-Stage4 |
4.528000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.89529999986505E-07 |
| Normal-vs-AfricanAmerican |
3.006000E-04 |
| Normal-vs-Asian |
9.048000E-01 |
| Caucasian-vs-AfricanAmerican |
9.476600E-01 |
| Caucasian-vs-Asian |
4.791000E-01 |
| AfricanAmerican-vs-Asian |
4.875000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1474999950245E-08 |
| Normal-vs-Female |
2.783600E-01 |
| Male-vs-Female |
1.552270E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.081800E-03 |
| Normal-vs-Extreme_Weight |
2.7576999572787E-09 |
| Normal-vs-Obese |
1.852360E-02 |
| Normal-vs-Extreme_Obese |
2.139700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.292600E-01 |
| Normal_Weight-vs-Obese |
4.319600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.310200E-01 |
| Extreme_Weight-vs-Obese |
1.912460E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.456400E-01 |
| Obese-vs-Extreme_Obese |
3.428000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.950200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.47979999999215E-05 |
| Normal-vs-Age(61-80Yrs) |
7.40950000022167E-07 |
| Normal-vs-Age(81-100Yrs) |
3.590300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.637600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.830400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.836100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.246800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.842800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.263400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.55020457476485E-11 |
| Normal-VS-Type2 PRCC |
3.888800E-01 |
| Normal-VS-KIRP CIMP |
7.740400E-01 |
| Normal-VS-Unclassified PRCC |
1.018390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.837590E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.604300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.041260E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.458000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.174200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.503000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.317200E-03 |
| Normal-vs-N1 |
5.462800E-01 |
| Normal-vs-N2 |
8.623200E-01 |
| N0-vs-N1 |
1.230210E-01 |
| N0-vs-N2 |
4.772400E-01 |
| N1-vs-N2 |
9.985000E-01 |
|
|
